Jim Simons Coherus Bio Sciences, Inc. Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 394,828 shares of CHRS stock, worth $323,758. This represents 0.0% of its overall portfolio holdings.

Number of Shares

394,828

Previous 152,328 159.2%

Holding current value

$323,758

Previous $364,000 87.64%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$1.58 - $2.51 $383,150 - $608,675	242,500 Added 159.2%	394,828 $683,000
Q1 2024 May 13, 2024	BUY	$2.02 - $3.14 $307,702 - $478,309	152,328 New	152,328 $364,000
Q3 2022 Nov 14, 2022	SELL	$7.17 - $13.87 $1.09 Million - $2.12 Million	-152,700 Reduced 74.31%	52,800 $507,000
Q2 2022 Aug 12, 2022	BUY	$5.86 - $13.23 $242,604 - $547,722	41,400 Added 25.23%	205,500 $1.49 Million
Q1 2022 May 13, 2022	BUY	$10.92 - $16.41 $1.18 Million - $1.78 Million	108,300 Added 194.09%	164,100 $2.12 Million
Q4 2021 Feb 11, 2022	BUY	$15.81 - $18.99 $882,198 - $1.06 Million	55,800 New	55,800 $891,000
Q2 2021 Aug 13, 2021	SELL	$12.95 - $15.41 $2.99 Million - $3.56 Million	-230,700 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$14.42 - $21.39 $439,810 - $652,395	-30,500 Reduced 11.68%	230,700 $3.37 Million
Q4 2020 Feb 10, 2021	BUY	$16.56 - $18.94 $2.97 Million - $3.4 Million	179,300 Added 218.93%	261,200 $4.54 Million
Q3 2020 Nov 13, 2020	SELL	$17.41 - $19.89 $5.64 Million - $6.45 Million	-324,200 Reduced 79.83%	81,900 $1.5 Million
Q2 2020 Aug 13, 2020	BUY	$14.43 - $19.16 $4.71 Million - $6.25 Million	326,200 Added 408.26%	406,100 $7.25 Million
Q1 2020 May 14, 2020	SELL	$11.67 - $22.53 $561,327 - $1.08 Million	-48,100 Reduced 37.58%	79,900 $1.3 Million
Q4 2019 Feb 13, 2020	BUY	$16.33 - $21.37 $2.09 Million - $2.74 Million	128,000 New	128,000 $2.31 Million

Others Institutions Holding CHRS

# of Institutions

140

Shares Held

76.8M

Call Options Held

79.1K

Put Options Held

100K

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $63.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account